Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
Abstract Background Clinicians are less likely to prescribe guideline-recommended treatments to people with multimorbidity than to people with a single condition. Doubts as to the applicability of clinical trials of drug treatments (the gold standard for evidence-based medicine) when people have co-...
Main Authors: | Peter Hanlon, Laurie Hannigan, Jesus Rodriguez-Perez, Colin Fischbacher, Nicky J. Welton, Sofia Dias, Frances S. Mair, Bruce Guthrie, Sarah Wild, David A. McAllister |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-019-1427-1 |
Similar Items
-
Comorbidity, multimorbidity, dual diagnosis — synonyms or different terms?
by: O. M. Drapkina, et al.
Published: (2019-04-01) -
Multimorbidity and comorbidity in the Dutch population – data from general practices
by: van Oostrom Sandra H, et al.
Published: (2012-08-01) -
Rheumatic diseases and multimorbidity
by: E L Nasonov, et al.
Published: (2015-05-01) -
THE CONCEPT OF MULTIMORBIDITY IN RHEUMATOLOGIC PRACTICE
by: A. V. Gordeev, et al.
Published: (2014-09-01) -
HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study
by: Curtis L. Cooper, et al.
Published: (2019-08-01)